Table 1.
Patients | Gender | Age | Education | WTAR-Std | MMSE2 | UPDRS | Years since diagnosis | Hoehn-Yahr | Status at testing | DOPA equivalence |
---|---|---|---|---|---|---|---|---|---|---|
P1 | M | 75 | 21 | 107 | 27 | 17 | 3.5 | 2 | ON | 750 |
P2 | F | 77 | 12 | 108 | 30 | 24 | 4.5 | 3 | ON | 350 |
P3 | M | 60 | 15 | 123 | 30 | 12 | 2 | 1 | OFF | 0 |
P4 | F | 59 | 16 | 110 | 26 | 21 | 4 | 2 | ON | up to 600 |
P5 | F | 52 | 16 | 104 | 30 | 25 | 9 | 2 | ON | 700–1000 |
P6 | F | 63 | 13 | 102 | 29 | 21 | 2 | 2 | ON | 800 |
P7 | M | 65 | 19 | 104 | 26 | 47 | 14 | 4 | ON | 750 |
P8 | F | 72 | 14 | 104 | 27 | 22 | 10 | 2 | ON | 600 |
P9 | F | 68 | 16 | 113 | 30 | 29 | 10 | 2 | ON | 800 |
P10 | M | 60 | 14 | 107 | 27 | 57 | 2.5 | 3 | OFF | 600 |
P11 | M | 64 | 12 | 96 | 27 | 45 | 6 | 3 | ON | 150 |
P12 | M | 67 | 19 | 93 | 28 | 68 | 5 | 4 | OFF | 1550 |
P13 | M | 74 | 14 | 99 | 28 | 43 | 6 | 2 | ON | 200 |
P14 | F | 60 | 18 | 102 | 28 | 24 | 7 | 2 | ON | variable |
P15 | M | 37 | 17 | 113 | 30 | 10 | 5 | 2 | ON | 750 |
P16 | M | 65 | 18 | 123 | 30 | 26 | 2 | 2 | ON | 200 |
P17 | F | 62 | 28 | 125 | 30 | 10 | 8 | 1 | ON | 200–500 |
P18 | M | 80 | 13 | 121 | 28 | 25 | 9 | 2 | ON | 850 |
P19 | M | 61 | 19 | 123 | 29 | 10 | 1.5 | 1.5 | ON | 100 |
P20 | F | 69 | 18 | 122 | 26 | 18 | 2.5 | 2 | ON | 200 |
Patient | 9/20 F | 64.5 (9.5) | 16.6 (3.7) | 110 (9.9) | 28.3 (1.5) | 27.7 (16.1) | 5.7 (3.4) | 2.3 (0.8) | ||
Control | 12/22 F | 65.4 (6.1) | 16.2 (1.9) | 115.9 (6.6) | 28.9 (0.9) |